Login To Trade  |  About IIFL
  • NIFTY  8532.85  111.05 1.32%
  • SENSEX 28114.56  409.21 1.48%
  1. General
  2. Others

  3. Others

Cipla cuts prices on 3 anti-cancer drugs: reports

India Infoline News Service | Mumbai | November 08, 2012 12:51 IST

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

Drug maker Cipla has reduced the prices on three anti-cancer drugs — Erlotinib (ERLOCIP), Docetaxel (DOCETAX) and Capecitabine (CAPEGARD), according to reports.

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

BSE 709.20 [0.90] ([0.13]%)
NSE 709.05 [2] ([0.28]%)

***Note: This is a NSE Chart


Turn your smartphone into a powerful mobile trading platform - Know more!!!

Read more on: Cipla   
article
113110704863
Cipla cuts prices on 3 anti-cancer drugs: reports
Cipla cuts prices on 3 anti-cancer drugs: reports
Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.
http://www.indiainfoline.com/article/news-top-story/cipla-cuts-prices-on-3-anti-cancer-drugs-reports-113110704863_1.html
November 08, 2012 12:51 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Cipla
Others
$rawVideoFileUrl$
$videoPlayerUrl$
Recent Reports

Revival some time away

India Infoline Research Team / 10:30, Jul 13, 2015

Tourism Finance Corp (TFCIL), a niche financier of tourism related projects and activities, has witnessed a sharp moderation in loan growth from 32% in FY12 to just 1% in FY14

News